Teva Chief Jeremy Levin Quits Abruptly
Image by haaretz
Teva Pharmaceutical Industries announced Wednesday that its president and CEO for the past two years, Jeremy Levin, has agreed to step down.
The company, which is the world’s largest manufacturer of generic drugs, said that on an interim basis, the top spot would be filled by Eyal Desheh, Teva’s executive vice president and chief financial officer.
Just days before, Levin had denied a report by Channel 2 that he was considering resigning. Trading in shares of Teva were halted following the announcement of Levin’s departure.
“Since I joined Teva, we have made tremendous progress in setting a new course for the company,” Levin said following his resignation. “I wish the company and its people, who I respect greatly, every success. I look forward to pursuing new opportunities where I can continue to apply my experience and contribute to the evolution of the global pharmaceutical industry.”
Levin’s departure follows a rift between company management and its board following public criticism of Teva for plans to lay off 5,000 worldwide and over tax incentives the firm received in Israel.
For more go to Haaretz
I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward’s award-winning, nonprofit journalism during this critical time.
Now more than ever, American Jews need independent news they can trust, with reporting driven by truth, not ideology. We serve you, not any ideological agenda.
At a time when other newsrooms are closing or cutting back, the Forward has removed its paywall and invested additional resources to report on the ground from Israel and around the U.S. on the impact of the war, rising antisemitism and the protests on college campuses.
Readers like you make it all possible. Support our work by becoming a Forward Member and connect with our journalism and your community.
Make a gift of any size and become a Forward member today. You’ll support our mission to tell the American Jewish story fully and fairly.
— Rachel Fishman Feddersen, Publisher and CEO
Join our mission to tell the Jewish story fully and fairly.
